Mylan N.V. (MYL -1.2%) initiates a voluntary nationwide recall of three lots of Nizatidine Capsules, USP, including the 150 mg and 300 mg strengths, due to trace amounts of N-nitrosodimethylamine (NDMA) in product manufactured by Tamilnadu, India-based Solara Active Pharma Sciences Limited.
The company has informed the FDA about the issue.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.